Understand the source comparison
Orforglipron Before and After Real Results Comparison
| Medication | Delivery Method | Mean Weight Loss (%) | Time to 5% Loss | GI Side Effect Peak | Storage Requirement | Professional Assessment ||—|—|—|—|—|—|| Orforglipron 45mg | Oral daily pill | 14.7% at 36 weeks | 12 weeks | Weeks 4–8, then resolves | Room t
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- | Medication | Delivery Method | Mean Weight Loss (%) | Time to 5% Loss | GI Side Effect Peak | Storage Requirement | Professional Assessment ||—|—|—|—|—|—|| Orforglipron 45mg | Oral daily pill | 14.7% at 36 weeks | 12 weeks | Weeks 4–8, then resolves | Room temperature stable | First oral GLP-1 to match injectable efficacy without absorption enhancers. Removes cold-chain and injection barriers entirely || Semaglutide 2.4mg (Wegovy) | Subcutaneous weekly injection | 14.9% at 68 weeks | 12–16 weeks | Weeks 4–12, persists longer | Refrigeration required (2–8°C) | Gold standard injectable. Proven cardiovascular benefits but requires injection training and cold storage || Rybelsus (oral semaglutide) 14mg | Oral daily pill | 5–6% at 68 weeks | 20+ weeks | Weeks 4–16 | Room temperature stable | Oral convenience but requires fasting protocol and delivers half the weight loss of injectable semaglutide || Tirzepatide 15mg (Zepbound) | Subcutaneous weekly injection | 20.9% at 72 weeks | 10–12 we